vimarsana.com

Latest Breaking News On - Angelo gaffo - Page 1 : vimarsana.com

Early Marker Found for Long-Term Gout Flare Potential

And the bad news: urate-lowering therapy seemed to make no difference

United statesUnited kingdomGreat britainJohn geverNatalie mccormickAngelo gaffoUniversity of alabama at birminghamMassachusetts general hospitalUnited kingdom biobankManaging editor

Review Discusses Common Missteps in Treating Patients With Gout and CKD

Reviewers discuss approaches and missteps in managing gout and hyperuricemia in patients with chronic kidney disease (CKD).

Angelo gaffoVijay kannuthuraiUniversity of alabama at birmingham

Two Elevated Biomarkers Distinguish Blacks with Resistant Hypertension

Researchers call for a wider study of racial differences in high blood pressure after finding two clinical measures that are significantly greater in Blacks with resistant hypertension

United statesScott ballingerThomass denneyJasvinder singhDavid calhounTonyr merrimanJamellea brownAngelo gaffoPaul sandersSuzanne oparilLouisj dellitaliaSteveng lloydEric kelleyHeersink school of medicineVirginia universityNational institutes of health

COVID-19 Collection

COVID-19 Collection
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

United statesTong tangLing chenMary wuYuquan weiDavidj kelvinBarbara bodinierAlice desclauxOliver ealesMarcello candelliOlivia leoniTonyr merrimanAlberto zoliXiawei weiNatalia paulenka ivanovovaHilde engjom

COVID-19 Collection

COVID-19 Collection
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

United statesTong tangLing chenMary wuYuquan weiDavidj kelvinBarbara bodinierAlice desclauxOliver ealesMarcello candelliOlivia leoniTonyr merrimanAlberto zoliXiawei weiNatalia paulenka ivanovovaHilde engjom

vimarsana © 2020. All Rights Reserved.